Department of Addiction Studies, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Department of Internal Medicine, Faculty of Medicine, Azad Ardabil University of Medical Sciences, Ardabil, Iran.
Drug Dev Res. 2023 Nov;84(7):1411-1426. doi: 10.1002/ddr.22110. Epub 2023 Aug 21.
Drug addiction as a problem for the health of the individual and the society is the result of a complex process in which there is an interaction between brain nuclei and neurotransmitters (such as glutamate). β-lactam antibiotics, due to their enhancing properties on the glutamate transporter glutamate transporter-1, can affect and counteract the addictive mechanisms of drugs through the regulation of extracellular glutamate. Since glutamate is a key neurotransmitter in the development of drug addiction, it seems that β-lactams can be considered as a promising treatment for addiction. However, more research in this field is necessary to identify other mechanisms involved in their effectiveness. This article is a review of the studies conducted on the effect of β-lactam administration in preventing the development of drug addiction, as well as their possible cellular and molecular mechanisms. This review suggests the clinical use of β-lactam antibiotics that have weak antimicrobial properties (such as clavulanic acid) in the treatment of drug dependence.
药物成瘾作为个人和社会健康的问题,是大脑核团和神经递质(如谷氨酸)相互作用的复杂过程的结果。β-内酰胺类抗生素通过调节细胞外谷氨酸,可以增强谷氨酸转运体-1 的作用,从而影响和对抗药物成瘾机制。由于谷氨酸是药物成瘾发展过程中的关键神经递质,因此β-内酰胺类抗生素似乎可以被认为是一种有前途的成瘾治疗药物。然而,还需要在这一领域进行更多的研究,以确定它们在有效性方面涉及的其他机制。本文综述了关于β-内酰胺类药物在预防药物成瘾发展方面的作用的研究,以及它们可能的细胞和分子机制。这一综述表明,在治疗药物依赖时,可以使用具有较弱抗菌特性的β-内酰胺类抗生素(如克拉维酸)。